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Murva is an important drug in Ayurveda. Wattakaka volubilis is used as one of the botanical sources of 
Murva. The aim of this study is to evaluate the effect of the alcohol extract of W. volubilis root in streptoztocin 
(STZ) induced diabetes and diabetic neuropathy. Diabetes mellitus (DM) was induced by the administration 
of STZ (45 mg/kg, i.p). DM was induced within 72 h. Diabetic animals were treated with glimepiride (0.5 
mg/kg) and ethyl alcohol extract 100 and 200 mg/kg for 21 d. After determining the changes in fasting 
serum glucose and lipid profile, animals were further treated for a period of 15 d to determine the protective 
effect of extract against diabetic neuropathy. All the alcohol extract treated animals, showed a significant 
decrease in serum glucose level (P<0.001), and overall decrease in the severity of diabetic neuropathy. 
Alcohol extract of W. volubilis root showed antihyperglycemic activity and beneficial protection against 
diabetic neuropathy and hence can be a promising agent for treatment and prevention of diabetic neuropathy.
Uniterms: Diabetes mellitus/study. Diabetic neuropathies. Wattakaka volubilis (L.f.) Stapf/ root/induced 
diabetes
INTRODUCTION
Diabetes is a serious metabolic disorder characterised 
by altered carbohydrate, lipid and protein metabolism 
which causes hyperglycemia resulting from insufficient 
insulin secretion, insulin action or both (Joseph, Jini, 
2011).
Diabetic patients are predisposed to many problems 
associated with their disease and one of the most prevalent 
complications in diabetes is diabetic neuropathy which 
affects about 50% of diabetic patients. Diabetic neuropathy 
affects pain fibres, motor neurons, and the autonomic 
nervous system (Pirart, 1978), resulting in foot ulcers or 
injury leading to amputation in more than 80% of cases 
(Boulton et al., 2005). Several pathways originating from 
hyperglycemia induce oxidative stress leading to diabetic 
neuropathy viz. formation of advanced glycation end 
products (AGEs) (Sugimoto, Yasujima, Yagihashi, 2008), 
polyol pathway activation, aldol reductase activation 
(Srivastava, Ramana, Bhatnagar, 2005) and activation of 
protein kinase C (PKC) (Yamagishi et al., 2008).
Due to its multifactorial nature, the treatment of 
this disease is difficult and treatment options are limited. 
This has led to increased exploration of alternative drugs 
from natural sources, having potent antidiabetic as well 
as neuroprotective activity.
Wattakaka volubilis (L.f) Stapf, a tall, woody 
climber belonging to the family Asclepiadaceae has been 
selected for the study. W. volubilis is also known as cotton 
milk plant and green wax flower (Gurudeva, 2001) and is 
used as an alternative source of Marsdenia tenacissima 
(Roxb.) Moon, which is the accepted botanical source 
of the drug Murva in Ayurveda (Yoganarasimhan, 
2000). Murva is used for the treatment of colic pain 
and possesses purgative, anthelmintic, antimutagenic, 
anticancer, antibacterial properties and it is used as an 
ingredient in several Ayurveda formulations (Levekar 
et al., 2007). 
The reported uses for W. volubilis are as follows. 
The plant juice is used as sternutatory and roots and 
tender stalks are used as emetic, purgative and expectorant 
(Yoganarasimhan, 2000). Leaves are used to treat 
rheumatic pain, cough, fever and severe cold (Muthu 
et al., 2006). The roots and leaves are used to treat skin 
diseases, diabetes, cough, jaundice, poison bites and for 
blood disorders (Rajadurai et al., 2009). Roots are used 
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in the treatment of kidney stones; leaf paste is taken along 
with pepper to treat dyspepsia (Singh, Govil, Singh, 2007). 
It is also used to treat rheumatic pain, cough, fever, severe 
cold, boils and abscesses (Rajadurai et al., 2009; Silija, 
Varma, Mohanan, 2008). Paste of its bark is mixed with 
hot milk and used internally for treating urinary trouble. 
Powder of its leaves when taken leaf powder taken orally 
along with cow’s milk is reported to have anti-diabetic 
activity (Pandi, Ayyanar, Ignacimuthu, 2007). Juice of 
leaf is used to cure sprain (Sanyasi, 2008). W. volubilis 
is also used in the treatment of scorpion and snake bites 
(Jain, Verma, 1981). 
Several phytoconstituents have been reported on 
W. volubilis. Root revealed the presence of steroids, 
triterpenoids, phenolic compounds and flavonoids 
(Joshi, Anvekar, Bhobe, 2013). N-[4-bromo-n-butyl]-
2-piperidinone and digitoxose have been isolated 
and characterized from the root (Joshi et al., 2013). 
Bark contained β-sistosterol, pregnane glycosides and 
kaempferol (Rastogi and Mehrotra, 1985). β-sitosterol; 
aglyconedrevogenin A; 9,12–octadecadienoic acid; quinic 
acid; 1,2– benzenedicarboxylic acid diisooctyl ester; 
5,7–dihydroxy–6,8–dimethoxyflavone have been reported 
on the root (Joshi, Anvekar, Bhobe, 2013). HPTLC 
evaluation of methanol extract of leaf of W. volubilis 
revealed the presence of oleonolic acid and ursolic acid 
(Gopal, Mandal, Mandal, 2014).Three polyoxypregnane 
glycosides, volubiloside A, B and C were isolated from 
the flowers (Shau et al., 2002). An unusual triterpenoid 
ether, multiflor-7-en-12, 13-ether and a new multiflor-
7-en-12α-ol was reported in the plant (Niranjan et al., 
2002). Glycosides dregeosides H, Dp1, Da1, Gp1, Ga1 
and two biosides were isolated from the hydrolysate of 
glycosides from roots vide Rastogi and Mehrotra (1985). 
Seven new glycosides dregeosides Ap1, Ao1, Aa1, A11, 
C11, Kp1 and Kal, Drevogenin D were isolated from 
the seeds. They were characterised as 3β, 11β, 12β, 14β, 
20ξ-pentahydroxypregn-5-enevide Rastogi and Mehrotra, 
(1980-1984).
W. vo lub i l i s  roo t  has  been  eva lua ted  fo r 
antiurolithiatic (Singh, Govil, Singh, 2007) and antipyretic 
activities (Madhavan et al., 2010); leaf has been evaluated 
for anti-diabetic, anti-hyperlipidemic and antioxidant 
properties (Mohan, Maruthupandian, Sampathraj, 
2010), wound healing property (Madhavan et al., 2012); 
antibacterial efficacy of root, stem and leaf have been 
reported (Shibu, Dhanam, 2013).Acute toxicity study of 
root also has been reported (Madhavan et al., 2010).The 
in vitro hypoglycaemic activity of Marsdenia tenacissima 
(Nayak, 2014) and antidiabetic activity of W. volubilis 
leaf have been scientifically validated, but no such study 
has been reported on root. Hence, the present study was 
undertaken to determine the anti-hyperglycemic activity of 
the alcohol extract of W. volubilis root and also to explore 
the possibility of its use in diabetic neuropathy. 
MATERIAL AND METHODS
Collection of plant material and preparation of 
ethanol extract
The plant material was collected during March 
2009 from Kalakkad forests, Tirunelveli district, Tamil 
Nadu in flowering condition. The plant was identified by 
Dr. S. N. Yoganarasimhan, Plant Taxonomist using Flora 
of the Presidency of Madras (2005) and Flora of Hassan 
District (1976). Herbarium specimen (031) was prepared 
as per Jain, Rao (1985) following International herbarium 
curatorial practices and deposited in the herbarium at the 
Department of Pharmacognosy, Faculty of Pharmacy, M. 
S. Ramaiah University of Applied Sciences, Bangalore.
Powdered shade dried root of W. volubilis was 
subjected to extraction with 95% v/v ethanol in a soxhlet 
apparatus by continuous hot percolation. The alcohol 
extract was filtered and concentrated to dryness. The 
percentage yield was calculated (5.67% w/w). The color 
and consistency of the extracts were noted (dark brown 
and sticky semisolid mass). The extract was suspended in 
2% w/v acacia solution and used for further studies.
Preliminary phytochemical analysis and HPTLC 
studies
The alcohol extract was subjected to preliminary 
phytochemical analysis (Kokate, 1999) for detection 
of different constituents. Chromatographic studies 
were carried out following Harborne, (1998) and Stahl, 
(2005). HPTLC studies were carried out using Camag 
HPTLC system equipped with Linomat V applicator, TLC 
scanner 3, Reprostar 3 with 12bit CCD camera for photo 
documentation, controlled by Win CATS- 4 software. All 
the solvents used were of HPTLC grade obtained from 
MERCK. TLC aluminum sheet precoated with silica 
gel 60 F254, (10 × 10 cm) was used as stationary phase. 
Chamber saturation was done overnight. Alcohol extract 
solution (5 mg/mL, 4 μL), was applied in duplicate, as 
tracks 1-2, with a band length of 6 mm each on a precoated 
silica-gel 60 F254 TLC plate, with Linomat V applicator 
using a Hamilton syringe. No prewashing of the plate was 
done. The mobile phase used was chloroform: methanol 
(8:2). Chamber was saturated overnight. TLC plates were 
kept for development, to a migration distance of 90 mm 
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for alcohol. No post derivatization was done for alcohol 
extract. The developed plates were dried and scanned 
successively at wavelengths of 254 nm, 366 nm and 425 
nm, band width, slit dimension, scanning speed and the 
source of radiation was deuterium, tungsten and mercury. 
The Rf and peak area of the spots were interpreted by using 
software (Wagner, Bladt, 1996).
Animals
Inbred albino Wistar rats, 8-12 weeks old, weighing 
200-250 g of either sex were used in the study. The rats were 
kept in properly numbered large polypropylene cages with 
stainless steel top grill having facilities for pelleted food. 
The animals were maintained in 12 h light and dark cycle 
at 28 °C ± 2 °C in a well-ventilated animal house under 
natural conditions and were acclimatized to laboratory 
conditions for 10 days prior to the commencement of the 
experiment. Paddy husk was used as bedding material. 
The animals were fed with standard pelleted diet. Prior 
approval was obtained from the Institutional Animal 
Ethics Committee of the institution (IEAC certificate no. 
MSRCP/M-41/2014).
Acute toxicity study
Limit test at 2000 mg/kg was performed as per 
OECD guidelines 423. Female albino Wistar rats 
were used in the study. A limit test at 2000 mg/kg was 
performed. The alcohol extract was administered orally to 
6 animals. Animals are observed individually after dosing 
at least once during the first 30 minutes, periodically 
during the first 24 hours, with special attention given 
during the first 4 hours, and daily thereafter, for a total 
of 14 days.
Induction of diabetes (Vogel et al., 2002)
Standardization of STZ dose was done at doses 35, 
45, 50, 55, 60 and 65 mg/kg with 3 animals at each dose 
level. Based on the observations, 45 mg/kg was selected 
as the dose for further studies. 
Animals were challenged with single injection of 
streptozotocin (STZ) at the dose of 45 mg/kg, i.p. After 
the injection, animals were allowed to drink 5% glucose 
solution overnight (Koneri et al., 2014). Development of 
hyperglycemia was confirmed 72 h after STZ injection. 
Experimental design
Non diabetic rats were assigned as the normal 
control group (Group I) and the rats with fasting serum 
glucose levels above 180 mg/dl at 72 h after STZ injection 
were considered diabetic and were divided into four 
groups of six animals each as follows:
Group II (Positive control) - Vehicle treated (Acacia 2% 
w/v p.o) treated diabetic rats;
Group III (Standard) - Glimepiride treated (0.5 mg/kg, 
b.w, p.o) diabetic rats;
Group IV - Alcohol extract treated (100 mg/kg, b.w, p.o) 
diabetic rats;
Group V - Alcohol extract treated (200 mg/kg, b.w, p.o) 
diabetic rats.
The treatment was started 72 h (considered as day 
1) post induction of diabetes. The animals were treated 
once daily for a period of 21 days. On the 22nd day, 
animals were made to fast overnight, anaesthetized with 
anaesthetic ether and blood was withdrawn from the retro 
orbital plexus. Serum was separated from the blood by 
centrifuging at 3000 rpm for 10 min (Micro Centrifuge, 
REMI Motors Ltd Mumbai)and the following parameters 
fasting blood glucose (Trinder, 1969), triglyceride (TG) 
(Abell, 1958) total cholesterol (TC) (Assmann., 1990; 
Bablock, 1988), albumin (Dumas, Watson, Biggs, 1997), 
High density lipoprotein (HDL) (Assmann, Schriewer, 
Schmitz, 1983) were estimated.
Diabetic neuropathy
Treatment was continued from the 22nd day onwards 
for further 15 d to evaluate the effects of the extract on 
diabetic neuropathy. Response of diabetic animals to pain 
stimuli was measured by Eddy’s hot plate method and 
acetic acid induced writhing test (Koneri et al., 2014). 
The response of animals to pain stimuli was assessed to 
study the effects of W. volubilis root extract on diabetes 
induced neuropathy.
Analgesic activity by Eddy’s hot-plate method
Each rat was placed on the hot plate maintained at 
55-56 °C and the time taken for the response to occur (either 
licking of paw or jumping) was recorded. A cut off time of 
15 s was kept to avoid damage to the paw of the animal.
Acetic acid writhing method
Animals were treated with 1% v/v acetic acid and 
placed individually under observations. The number 
of abdominal contractions, trunk twist response and 
extension of hind limbs response during a period of 10 
min were measured.
Subsequently, the animals were sacrificed for 
isolation of liver to estimate the glycogen content (Carroll, 
Longley, Roe, 1955; Van Der Vies, 1954).
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Statistical Analysis
The data were expressed as Mean ± S.E.M and were 
tested with one way ANOVA followed by Tukey-Kramer 
multiple comparison test
RESULTS
Phytochemical studies
Preliminary phytochemical analysis of the alcohol 
extract of W. volubilis root revealed the presence of 
saponins and glycosides.
HPTLC fingerprint of the alcohol extract of W. 
volubilis root was obtained at wavelengths 254, 366 and 
425 nm. At 254 nm, 3 peaks were observed at Rf 0.28, 0.34, 
0.66; 13 peaks were observed at Rf 0.12, 0.23, 0.31, 0.41, 
0.45, 0.52, 0.56, 0.60, 0.67, 0.69, 0.80, 0.86 and 0.93 at 366 
nm and 4 peaks at Rf0.27, 0.55, 0.72, 0.92 were observed 
at 425 nm (Figure 1).
Acute toxicity study
Oral administration of ethanol extract of W. 
volubilis at 2000 mg/kg did not produce any symptoms 
of toxicity or death in female Wistar rats. The doses for 
the pharmacological studies were chosen based on these 
results.
Effect on body weight 
There was an increase in the mean body weight 
of normal control from 224.5±4.682 g on day 1 to 
252.33±2.12 g on day 21. There was a significant decrease 
in the body weight (P<0.001) of untreated diabetic rats 
from 211.16±2.89 g on day 1 to 51.83±2.70 g on day 21. 
Animals treated with the extract significantly (P<0.001) 
gained weight and the observations were comparable with 
glimepiride (0.5 mg/kg) (Table I). 
Effect on serum parameters
Serum glucose
Administration of streptozotocin 45 mg/kg, b.w, i.p, 
produced significant (P<0.001) increase in blood glucose 
levels compared to the normal control animals. Diabetic 
rats treated with 100 and 200 mg/kg b.w of the alcohol 
extract showed fasting serum glucose levels of 197.63 
± 1.25 and 201.34 ± 2.93 mg/dl on day 0 which was 
significantly reduced to 169.83 ±2.11 and 131.37 ± 2.07 
mg/dl on day 21 respectively. Results were statistically 
significant (P< 0.001) (Table I). 
Lipid profile
The STZ induced diabetic rats (positive control) 
showed significant (P<0.001) elevation of serum 
cholesterol, serum triglyceride levels and reduction in 
HDL levels compared to the normal control. There was a 
significant (P<0.001) reduction in the serum cholesterol, 
serum triglyceride levels and significant elevation in serum 
HDL levels in all the extract treated (100 and 200 mg/kg) 
and glimepiride treated groups (Table II). 
Serum albumin
Serum albumin concentration in the positive 
control was 2.60 ± 0.11g/dLwhich was significantly 
lower (P<0.001) than that of normal control (6.10 ± 0.03 
g/dL). An elevation in serum albumin levels (P<0.001) 
were observed in extract treated (100 and 200 mg/kg) 
and glimepiride treated groups of diabetic rats (Table II).
Liver glycogen
The liver glycogen content in normal group and 
positive control group of rats was found to be 2681.59 ± 
67.56 mg and 788.60 ± 20.5 mg respectively. This shows 
that there was a significant decrease (P<0.001) in liver 
glycogen content in the diabetic control when compared 
with the normal control animals. Treatment with 100, 
200 mg/kg of alcohol extract and glimepiride showed 
significant improvement (P<0.001) in liver glycogen 
content. Results are tabulated in (Table II).
Effects on diabetic neuropathy
The response to pain stimuli was assessed by hot 
plate method and acetic acid writhing methods. 
Hot plate response time in STZ diabetic rats 
(12.33±0.71s) was found to be significantly higher 
FIGURE 1 - HPTLC fingerprint of alcohol extract of W. volubilis 
root at 425 nm.
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(P<0.001) than the normal rats (1.66±0.33 s). Hot plate 
response time in STZ diabetic rats administered with 
alcohol extract 100, 200 mg/kg and glimepiride (0.5 mg/
kg) was found to be 4.83±0.30 s, 3.83±0.30 s and 5.0±0.60 
s, respectively, which was significantly lower (P<0.001) 
than that of diabetic control.
Diabetic control rat showed 8.5±1.0 writhing in 
ten minutes which is significantly lower (P<0.001) in 
comparison with the normal group (32.66±0.88 writhing 
in ten minutes). Number of writhing showed by diabetic 
rats administered with 100, 200 mg/kg and glimepiride 
was found to be 14.83±1.42, 19.66±1.43 and 15.66±0.66, 
respectively, which was significantly higher (P<0.001) 
than the results observed with the diabetic control. Results 
are presented in Table III.
Histopathology examination 
Liver-histologic examination of liver of normal rats 
showed normal hepatic architecture with a central vein 
while the diabetic liver showed periportal fatty infiltration 
with focal fat necrosis, lymphocyte infiltration, 
ballooning degeneration and dilated sinusoids. The 
extract as well as glimepiride treated diabetic rats showed 
TABLE I - Effect of alcohol extract of W. volubilis root on body weight and serum glucose in Wistar rats 
Groups
Body weight Serum glucose (mg/dL)
Before treatment after treatment before treatment after treatment
Normal control (2% w/v acacia) 224.5±4.68 252.33±2.12 88.70 ± 1.17 97.40 ± 1.42
Diabetic control 211.16±2.89 51.83±2.70a 191.20±3.30 226.90±2.66a
Standard (Glimepiride) 211.33±2.87 189.5±3.00*** 197.60 ±1.33 125.70±2.60***
Alcohol extract (100 mg/kg) 217.33±2.26 167.33±2.44*** 197.63 ± 1.25 169.83 ±2.11***
Alcohol extract (200 mg/kg) 214.16±2.00 176.66±3.50*** 201.34 ± 2.93 131.37 ± 2.07***
Values are expressed as Mean ± SEM; n=6. One-way ANOVA: P value found to be 0.0001;Tukey-Kramer multiple comparisons 
test: aP< 0.001 in comparison with normal control; ***P<0.001 in comparison with the positive control
TABLE II - Effect of alcohol extract of W. volubilis root on serum parameters in Wistar rats 
Parameters Normal control Diabetic control Standard (Glimepiride)
Alcohol extract 
(100 mg/kg)
Alcohol extract 
(200 mg/kg)
Serum TG (mg/dL) 139.74 ± 2.36 196.35 ± 6.64a 158.00 ± 1.51*** 140.30 ± 3.14*** 117. 30 ± 2.75***
Serum TC (mg/dL) 136.0 ± 2.22 221.70 ± 6.22a 149.58 ± 1.95*** 169.82 ± 2.11*** 131. 37 ± 2.07***
Serum albumin (g/dL) 6.10 ± 0.03 2.60 ± 0.11a 5.17 ± 0.25*** 6.01 ± 0.13*** 5.65 ± 0.12***
Serum HDL (mg/dl) 81.78 ± 1.87 35.75 ± 2.07a 57.09 ± 1.61*** 101.90 ± 2.14*** 92.53 ± 2.93***
Liver glycogen (mg) 2681.59 ± 67.56 788.60 ± 20.5a 1996.90 ± 66.16*** 1809.40 ± 64.00*** 2484.30 ± 160.04***
Values are expressed as Mean ± SEM; n=6. One-way ANOVA: P value found to be 0.0001;Tukey-Kramer multiple comparisons 
test: aP< 0.001 in comparison with normal control; ***P<0.001 in comparison with the positive control
TABLE III - Effect of alcohol extract of W. volubilis root on diabetic neuropathy in Wistar rats
Groups Hot plate response time (s) No. of writhing in ten min
Normal control (2% w/v acacia) 1.66±0.33 32.66±0.88
Diabetic control 12.33±0.71a 8.5±1.00 a
Standard (Glimepiride) 5.0±0.60*** 15.66±0.66**
Test 1 (100 mg/kg) 4.83±0.30*** 14.83±1.42***
Test 2 (200 mg/kg) 3.83±0.30*** 19.66±1.43***
Values are expressed as Mean ± SEM; n=6. One-way ANOVA: P value found to be < 0.0001;Tukey-Kramer multiple comparisons 
test:aP< 0.001 in comparison with normal control; ***P<0.001 in comparison with positive control; **P<0.01 in comparison with 
positive control
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normal hepatic architecture with narrower sinusoids 
(Figure 2A-2E).
Pancreas-Histologic examination of pancreas 
in normal rats revealed normal architecture showing 
pancreatic acini and connective tissue. The diabetic 
group showed highly dilated blood vessels and marked 
degeneration in pancreas. The extract treated groups as 
well as glimepiride treated group showed normal lobular 
architecture with connective tissue (Figure 3A-3E).
DISCUSSION
Streptozotocin, a broad spectrum antibiotic which 
has been widely used for inducing the diabetes mellitus 
in a variety of animals by causing degeneration and 
necrosis of pancreatic β-cells (Junod et al., 1969). 
STZ is a 2-deoxy-glucose derivative of the carcinogen 
N-methyl-N-nitrosourea (MNU) and belongs to a group 
of alkylating antineoplastic drugs known as alkylating 
FIGURE 2 - A - Liver normal control; B-Diabetic control; C-Standard (glimepiride); D-Alcohol extract (100 mg/kg); E-Alcohol 
extract (200 mg/kg). CV-Central vein; NS- Narrow sinusoids; DSN-Dilated sinusoids; FN-Fatty necrosis; BD-Ballooning 
degradation.
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nitrosoureas (Bolzain, Bianchi, 2002). It is taken up by the 
pancreatic β-cells via glucose transporter GLUT2. STZ 
imposes toxicity on pancreatic β-islet cells (Rodrigues 
et al., 1997). By DNA modification through free radicals 
mechanism and DNA methylation STZ causes direct 
alkylation of DNA by reactive methyl carbonium ions 
(•CH3, CH3+) formed during the decomposition. Selection 
of an appropriate dose of STZ is a very important issue. 
Owing to strain differences (Rodrigues et al., 1997), the 
diabetogenic doses of STZ range from 45 to 70 mg/kg 
(Rakieten, Rakieten, Nadkarni, 1963).
In the present study, different doses of STZ were 
initially used for the standardisation of the dose for the 
development of DM. Doses 35, 45, 50, 55, 60 and 65 mg/
kg of STZ were administered. Injection of STZ produced 
abnormal abdominal contractions similar to writhing 
response for a brief period of time. During this evaluation, 
mortality was observed within 72 h in all animals receiving 
50, 55, 60, 65 mg/kg i.p. of STZ. Animals receiving the 
dose of 35 mg/kg i.p of STZ did not show any significant 
FIGURE 3 - A-Pancreas normal control; B-Diabetic control; C-Standard (glimepiride); D-Alcohol extract (100 mg/kg); E- Alcohol 
extract (200 mg/kg). PA-Pancreatic acini; DBV- Dilated blood vessels.
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increase in the blood glucose level. All animals which 
received 45 mg/kg i.p of STZ showed hyperglycemia 72 h 
after induction. Further, administration of 5% glucose 
solution during the first 24 h following STZ injection 
prevented early mortalities (Suresh, Srinivasan, 1997).
STZ at a dose of 45 mg/kg was used for the induction 
of DM as it showed significant hyperglycemia without any 
mortality. All the animals manifested with major clinical 
sign of DM such as polyphagia, polydypsia, polyuria 
and body weight reduction. Diarrhoea was observed in 
the initial few d. This was followed by development of 
constipation characterized by bulged abdomen.
Doses of 100 and 200 mg/kg of the alcohol extract 
of W. volubilis were selected for the antidiabetic activity 
studies based on the results of acute toxicity studies. The 
alcohol extract of W. volubilis root at a dose of 100 and 
200 mg/kg showed significant antihyperglycemic activity 
against STZ induced diabetes mellitus in rats, and the 
effects were comparable with that of the standard drug 
glimepiride.
Loss in body weight was observed in STZ-induced 
DM in rats and was controlled by treatment with alcohol 
extract of W. volubilis root. Administration of the extract 
to diabetic rats resulted in an increase in body weight. 
The findings of this study suggest that W. volubilis has 
a positive effect on maintaining body weight in diabetic 
animals.
Treatment of diabetic rats with different doses of 
alcohol extract reduced the elevated serum glucose at both 
the test dose levels, but the higher dose (200 mg/kg) was 
able to reduce the fasting serum glucose comparable with 
the reduction caused by treatment with glimepiride during 
the period of study.
Diabetes mellitus is usually associated with 
prominent levels of serum lipids and such an increase 
causes the risk factor for coronary heart diseases 
(Davidson, 1981). A variety of alterations in metabolic 
and regulatory mechanisms, due to insulin deficiency 
or due to insulin resistance are responsible for the 
observed accumulation of lipids (Rajalingam, Srinivasan, 
Govindarajulu, 1993). High levels of TC and TG are the 
predictors of atherosclerosis (Temme et al., 2002). In 
the present study, the test extract significantly reduced 
the TC and TG levels in treated diabetic rats compared 
to untreated diabetic rats. In fact, the TC and TG levels 
were lowered more significantly in the test dose group 
(200 mg/kg) than the standard (glimepiride) treated group. 
Several studies showed that increase in HDL cholesterol is 
associated with a decrease in coronary risk (Rajalingam, 
Srinivasan, Govindarajulu, 1993). In the present study, 
the extract significantly increased the levels of HDL 
cholesterol. This is an important advantage in treatment 
of hypercholesterolemia particularly in patients in whom 
low HDL cholesterol levels remain the most prevalent 
lipoprotein abnormality in DM (Gupta et al., 1994).
Diabetes is associated with a decrease in liver 
weight due to enhanced catabolic processes such as 
glycogenolysis, lipolysis and proteolysis (Yadav et al., 
2005) and therefore the quantification of glycogen, the 
primary intracellular storage form of glucose in liver 
can be considered as an important indicator of diabetes 
mellitus. Glycogen level in various tissues especially in 
liver and skeletal muscle indicates direct reflection of 
insulin activity since it causes glycogen deposition by 
stimulating glycogen synthase and inhibiting glycogen 
phosphorylase. Glycogen levels in tissues (muscle and 
liver) decrease as the influx of glucose in the liver is 
inhibited in the absence of insulin and recovers on insulin 
treatment (Ghahary et al., 1991).Treatment with the extract 
significantly increased the hepatic glycogen levels in the 
extract treated rats. 
Diabetic neuropathy is one of the common 
complications of diabetes mellitus. It affects all the 
peripheral nerves including pain fibres, motor neurons, 
and the autonomic nervous system (Pirart, 1978). There 
is a loss of pain perception in diabetes probably due to 
nerve damage and induction of peripheral neuropathy (Raz 
et al., 1988; Simon, Dewey, 1981). Thermal hypoalgesia 
has been reported in diabetic rats using the hot-plate test. 
In this study, streptozotocin-induced diabetic control rats 
showed significant hypoalgesia in the hot-plate (Tulaporn, 
Sithiporn, 2009; Zochodne et al., 2001).Acetic acid 
induced writhing was also evaluated as a parameter to 
demonstrate the pain sensitivity in diabetic animals. It was 
observed that animals treated with the extracts showed 
increased pain perception than the diabetic control or the 
standard group. This indicates the protective effect of the 
extract against diabetic neuropathy.
The findings of this study proved the anti-
hyperglycemic activity and neuroprotective effects of W. 
volubilis root. However, the glycemic levels could not 
be normalized by the 21 day treatment period. However, 
considering the short duration of the present study, a longer 
duration of study is required to attain normal glycemic 
levels in blood. 
Preliminary phytochemical analysis revealed the 
presence of glycosides and saponins. Several authors have 
reported the antidiabetic principles of saponins (Li et al., 
2002; Jang et al., 2000). Hence, the antihyperglycemic 
activity and the protective effect of W. volubilis root 
extract against diabetic neuropathy could be due to the 
presence of these phytoconstituents. However, further 
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studies like isolation of the phytoconstituents and their 
pharmacological evaluation are needed to substantiate 
the claim.
CONCLUSION
This study confirms the anti-hyperglycemic activity 
and neuroprotective effects of W. volubilis root in rats in 
the tested model. Thus the study substantiates traditional 
claim of Murva vis-a-vis W. volubilis as an anti- diabetic 
drug. However, further studies are needed to elucidate 
the mechanism(s) of action and to identify the active 
principle/s responsible for producing these activities.
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